Barrow, Hanley, Mewhinney & Strauss’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3M Buy
392,240
+392,183
+688,040% +$58.2M 0.23% 100
2026
Q1
$5.31K Buy
+57
New +$5.05K ﹤0.01% 268
2025
Q3
Sell
-44
Closed -$3.07K 350
2025
Q2
$3.07K Buy
+44
New +$2.51K ﹤0.01% 283

Other funds holding ACLS

Barrow, Hanley, Mewhinney & Strauss's ACLS Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Axcelis (ACLS) stake by 688,040% in Q2 2026, buying an estimated $58.2M and bringing the position to 392,240 shares worth $74.3M. The position accounts for 0.23% of the portfolio, ranked #100.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ACLS in Q2 2025 and has held it in 3 quarters since. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 392,240 shares of Axcelis worth $74.3M as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 392,183 Axcelis shares in Q2 2026, an estimated $58.2M.
  • Axcelis made up 0.23% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #100 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Axcelis in Q2 2025 and has held it in 3 quarters since.
  • 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.